Kidney disease Flashcards

1
Q

What is the mechanism behind proximal (type 2) and distal (type 1) renal tubular acidosis

A
  • Proximal: decreased HCO3- reabsorption in proximal convoluted tubule (reduced transport maximum for HCO3-)
  • Distal: decreased H+ secretion in late distal convoluted tubule / collecting duct (decreased HCO3- production)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the serum bicarbonate, urine pH (without treatment), urine pH after NaHCO3 administration, bicarbonate therapy requirement for proximal / distal RTA

A
  1. Proximal RTA:
    - HCO3 = 15-18 mmol/L
    - Urine pH < 6 (in steady state)
    - Urine pH after NaHCO3 = alkaline
    - NaHCO3 requirement = > 10 mEq/kg/d
  2. Distal RTA:
    - HCO3 = < 10-12 mmol/L
    - Urine pH > 6
    - Urine pH after NaHCO3 = no change
    - NaHCO3 requirement = < 3 mEq/kg/d
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name causes of proximal and distal RTA

A
  1. Proximal:
    - Aminoglycoside toxicity
    - Fanconi syndrome (congenital: Basenjis)
    - Acetazolamide treatment
    - Cisplatin toxicity
    - Ethylene glycol toxicity
    - Leptospirosis
    - Multiple myeloma
    - Heavy metal toxicity
  2. Distal:
    - IMHA
    - Pyelonephritis
    - Multiple myeloma
    - Amphotericin B toxicity
    - Heavy metal toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a consequence of alkali therapy in proximal RTA

A

Worsening hypokalemia (due to presence of HCO3- in the urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a possible complication of distal RTA

A

Urolithiasis due to:
- increased calciuresis due to bone resorption from chronic metabolic acidosis
- alkaline urine reducing the solubility of Ca and P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a possible alternative to sodium bicarbonate therapy in dogs with RTA

A

Potassium citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the histological finding with NSAID toxicity

A

Papillary necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name 5 toxins affecting the renal tubule

A
  • Grapes
  • Ethylene glycol
  • Aminoglycosides
  • Cisplatin
  • Contrast agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 3 staging systems for AKI in humans

A
  • Risk Injury Failure End Stage Kidney Disease (RIFLE)
  • Acute Kidney Injury Network (AKIN)
  • Kidney Disease: Improving Global Outcomes (KDIGO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the IRIS AKI grading system

A
  1. Grade I: Non-azotemic AKI (creat < 140 umol/L)
    - Documented AKI (historical, clinical, lab, imaging) and/or
    - Increase in creatinine > 26 umol/L in 48h and/or
    - Oliguria < 1 mL/kg/h over 6h
  2. Grade II: Mild AKI (creat 141 - 220 umol/L)
    - Documented AKI and static or progressive azotemia and/or
    - Increase in creatinine > 26 umol/L within 48h and/or
    - Oliguria <1 mL/kg/h over 6h
  3. Grade III: Moderate to severe AKI (creat 221-439 umol/L)
    - Documented AKI and increasing severities of azotemia and functional failure
  4. Grade IV: creat 440-880 umol/L
  5. Grade V: creat > 880 umol/L

Each grade subdivided with non-oliguric or oliguric, and need for RRT or no need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 4 phases of the pathophysiology of AKI and their duration? What model are they based on?

A

Based on ischemic injury - might not apply to all types of injury

(0. Insult phase)

  1. Initiation phase (hours to days): cellular damage (decreased GFR but no clinical / biochemical changes)
  2. Extension phase (1-2 days): cellular death (biochemical and clinical manifestations start)
  3. Maintenance phase (days-weeks): simultaneous cell death and regeneration (GFR stabilizes, creatinine reaches a plateau)
  4. Recovery phase (weeks-months): improvement in GFR and tubular function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathophysiology of ischemic AKI

A

In initiation phase (hours - day):
1. Ischemia -> increase in intracellular Ca2+ -> ROS -> cellular damage + release of cytokines and chemokines

  1. Disruption of cytoskeleton and redistribution of Na/K ATPase to apical membrane -> entry of water in cells -> swelling -> tubular obstruction
  2. Relocation of integrins -> loss of cell anchorage to basal membrane ->cell desquamation, tubular obstruction + back-leakage of filtrate into interstitium

In extension phase (1-2 days):
1. Damaged endothelial cells -> expression of selectins, ICAM-1 responsible for leukocyte activation

  1. Endothelial glycocalyx shedding -> increased permeability -> edema -> hypoxia
  2. Sluggish flow in capillaries -> microthrombi -> capillary plugging -> ischemia

Maintenance phase (days-weeks):
- Stabilization of GFR
- Cell death vs regeneration

Recovery phase (weeks-months):
- Restoration of GFR
- reestablished cell polarity + tubular integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is the ultrasonographic architecture of the kidneys in most cases of AKI? What are exceptions?

A

Normal in most cases (or sometimes enlarged kidneys +/- perirenal fluid).

Exceptions:
- Lymphoma: thickened cortex with hypoechoic perirenal halo
- AKI on CKD
- Ethylene glycol: hyperechoic renal cortices and medulla
- Obstruction
- Pyelonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are indicators of ethylene glycol toxicosis

A
  • High anion gap metabolic acidosis
  • Calcium oxalate crystalluria (especially Ca oxalate monohydrate)
  • Hyperechoic renal cortices and medullary rim sign
  • Hyperlactatemia in some analyzers
  • Hypocalcemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are diagnostic criteria for Leptospirosis based on serology? Which serovar is the most at risk of false positive?

A
  • Initial titers of >1:800 with clinical suspicion (L autumnalis most at risk of false positive from cross-reactivity with vaccines)
  • OR 4-fold increase in titers after 2-4 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommended rate of fluid tapering for patients recovering from AKI

A

Decrease rate by 10-25% per day as long as urine output decreases accordingly and weight and perfusion remain stable
(LOL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the mortality rate from AKI in dogs and cats

A
  • Dogs: 45% mortality (but survival up to 82-86% for lepto)
  • Cats: 53% mortality

(Among surviving patients, about 50% will have chronic kidney disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the most common cause of CKD in cats and dogs

A

Cats: often unknown
Dogs: glomerular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the most common histologic lesions in cats and dogs with CKD

A

Cats: lymphoplasmocytic tubulointerstitial nephritis and fibrosis
Dogs: glomerular lesions and interstitial nephritis with common lipid infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Described the IRIS CKD staging system

A
  1. Stage based on creatinine
    - Stage I: creat < 125 (dogs) or 140 (cats)
    - Stage II: creat 125-250 (dogs) or 140-250 (cats)
    - Stage III: creat 251-440
    - Stage IV: creat > 440
  2. Substage based on UPCR
    - Nonproteinuric: UPCR<0.2
    - Borderline proteinuric: UPCR 0.2-0.5 (dogs) or 0.2-0.4 (cats)
    - Proteinuric: UPCR>0.5 (dogs) or 0.4 (cats)
  3. Substage based on BP
    - Normotensive: SBP<140
    - Prehypertensive: SBP 140-159
    - Hypertensive: SBP 160-179
    - Severely hypertensive: SBP > 180
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

True or false: a USG>1.030 rules out CKD

A

False.

Some dogs and cats will have a CKD despite USG>1.030 (susp secondary to the presence of lipids in the urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What UPCR is suggestive of glomerular disease

A

UPCR >2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Name some congenital nephropathies in dogs and cats (with associated breeds)

A
  1. Dogs:
    - Renal dysplasia (Lhassa Apso, Shih Tzu, Wheaten Terrier, Standard Poodle)
    - Primary glomerulopathy (Cocker Spaniel Springer Spaniel, Bull Terrier)
    - Polycystic kidney disease (Bull Terrier, Cairn Terrier, Westie)
    - Amyloidosis (Shar Pei)
    - Immune mediated glomerulonephritis (Bernese Mountain Dog, Brittany Spaniel)
    - Fanconi syndrome (Basenji)
  2. Cats:
    - Plolycystic kidney disease (Persian)
    - Amyloidosis (Abyssinian, Siamese)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the median pelvic width in dogs and cats with ureteral obstruction

A

Dogs: 15 mm
Cats: 6.8 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Name a renal disease potentially identified on renal aspirates (one in dogs, one in cats)

A

Dogs: renal lymphoma
Cats: FIP (and renal lymphoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Are antacids indicated in the treatment of CKD

A

No - there is no evidence of increased gastric acidity or gastric ulceration ; antacids increase the burden of medications and are associated with AKI in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What variables are associated with decompensation / mortality in cats and dogs with CKD

A

Creatinine, UPC, urine albumin-to-creatinine ratio, leukocytosis, hyperphosphatemia, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Name a few possible post-op complications of kidney transplantation in cats

A
  • Graft rejection
  • Retroperitoneal fibrosis (causing ureteral obstruction)
  • Ureteral obstruction
  • Infections
  • Neoplasia (lymphoma)
  • Diabetes mellitus
  • Hemolytic uremic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are mechanisms of pathogenesis of oligoanuria

A
  • Decreased renal blood flow (hypovolemia, decreased CO, vasodilation, renal artery thrombosis)
  • Tubular obstruction from casts or cells (pyelonephritis, acute interstitial nephritis, acute tubular necrosis)
  • Backflow of glomerular filtrate in renal interstitium (tubular / pelvic / ureteral / urethral obstruction)
  • Intrarenal RAAS activation (high Cl fluids)
  • Altered permeability of glomerular capillaries (glomerulonephritis, vasculitis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What should be the IV fluid plan for a normovolemic oligo-anuric patient

A
  • Challenge with fluids to correct 3-5% dehydration (likely to be missed on physical exam)
  • If responds, match INs/OUTs
  • If does not respond, give fluids for insensible losses only (about 20 mL/kg/day, usually met with meds and flushes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Why is furosemide unlikely to be effective in anuric patients

A

Furosemide needs to reach the tubular fluid to be inhibit the Na-K-2Cl pumps (by active secretion in proximal tubule +/- some glomerular filtration). If there is no urine production furosemide will likely not reach its site of action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What medications can be given to attempt to convert oligoanuria to polyuria (+ mechanism of action and 1 adverse effect)

A
  • Mannitol: osmotic diuretic, can help wash out tubules from casts etc.
    Can worsen pulmonary edema and intracellular dehydration (not recommended in humans with AKI)
  • Furosemide: Na-K-2Cl transporter inhibitor (thick ascending limb of the loop of Henle).
    Can cause ototoxicity. Might increase urine volume but not GFR.
  • Dopamine: stimulates DA-1, DA-1, and alpha and beta-adrenergic receptors ; leads to afferent arteriole vasodilation (at low doses) + increases natriuresis by inhibition of tubular transporters.
    Can cause tachyarrhythmias.
  • Fenoldopam: selective dopamin receptor (DA-1) agonist leading to renal vasodilation.
    Can cause hypotension from systemic vasodilation.
  • Diltiazem: calcium channel blocker leading to afferent arteriole vasodilation
    Can cause hypotension.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Common bacteria responsible for UTIs in dogs

A
  • E Coli
  • Staphylococcus spp
  • Enterococcus spp
  • Proteus spp
  • Streptococcus spp
  • Klebsiella spp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What breeds are predisposed to Lyme nephritis

A

Retriever breeds

35
Q

What are typical physical examination / laboratory findings of Lyme nephritis

A
  • Lyme + status
  • Proteinuria
  • Hypoalbuminemia
  • Thrombocytopenia
  • Hypertension
  • Mild to moderate azotemia (USG 1.020-1.030 until late stages)
  • Hypercholesterolemia
36
Q

What family of ticks is responsible for transmission of Lyme disease? For how long does it need to be attached to the dog?

A

Ixodes (I scapularis, I pacificus, I ricinus)

Needs to be attached for 2 days

37
Q

Describe 5 diagnostic tests for leptospirosis

A
  1. Serology with micro-agglutination testing (MAT): Gold standard. Reports serum titer at which 50% of leptospires agglutinate (seen on darkfield microscopy) for 6-7 serovars (but cross-reactivity is frequent). Positive if >1:800 in acute titers (Se 50% only) or 4-fold increase in titers after 7-14 days.
    Affected by vaccination.
  2. PCR: Identifies leptospire DNA in blood and/or urine. Positive blood confirms lepto, positive urine can happen in 20% healthy dogs. False negatives are frequent due to short leptospiremic phase (<6 days) and intermittent urinary shedding (+ antibiotic use). Not affected by vaccination.
  3. Point-of-care serologic tests: SNAP Lepto (Idexx) detects IgG to LipL32. WITNESS Lepto (Zoetis) detects IgM for L Bratislava and Grippotyphosa.
    Can have false negative due to delay in antibody production (less for IgM) and false positive from vaccination (LipL32 supposed to be more specific of pathogenic lepto but still).
    Se and Sp vary with geographic location
  4. Darkfield microscopy: Direct observation of leptospires. Low sensitivity, requires expertise.
  5. Culture: Requires prolonged incubation time on special culture medium, difficult, low sensitivity
38
Q

What are mechanisms of AKI development in sepsis

A
  • Microcirculatory dysfunction: microthrombi, heterogeneous blood flow
  • Increased capillary permeability: peritubular interstitial edema, contributes to hypoxia of medulla
  • Glomerular shunt capillaries bypassing glomeruli (and medulla)
  • Inflammatory response and oxidative stress causing direct epithelial cell injury (ROS)
  • Epithelial damage causes decreased Na and Cl reabsorption -> increased delivery to macula dense -> decrease in GFR (tubuloglomerular feedback)
  • Epithelial damage also causes disruption of tight junctions with back-leakage of tubular fluid and shedding of epithelial cells (causing tubular obstruction)
  • Metabolic reprogramming of tubular cells favouring cell survival over transport functions (sublethal injury)
39
Q

What are possible mechanisms of nephrotoxicity

A
  1. Hemodynamically mediated (NSAIDs, ACEIs): decrease renal blood flow / GFR by vasoconstriction or afferent and efferent arterioles (NSAIDs) or vasodilation of efferent > afferent arteriole (ACEIs)
  2. Tubular necrosis (aminoglycosides, contrast agents): direct tubular cell injury from contact with toxin
  3. Interstitial nephritis (beta-lactams, PPIs): act as antigens, attract T cells and lead to inflammation
  4. Crystalline (ethylene glycol, methotrexate): crystal deposits in tubules causing obstruction + cytotoxic effect
40
Q

Is short term prognosis worse for cats and dogs with acute on chronic kidney injury vs AKI?

A

Not worse, even a little better (65% survival in dogs, 58% survival in cats) because more often caused by reversible cause.

Long term survival is not good though (median survival time 105 days in dogs, 66 days in cats)

41
Q

What is the long term outcome for dogs who survive AKI (in terms of long term survival and creatinine normalization)

A

Overall good prognosis. Creatinine normalization in 75% of dogs (55% before discharge, 20% after). Long median survival time with most dogs still alive or dead from other causes.

42
Q

Where is erythropoietin produced? Under what stimulation?

A

In the peritubular interstitial cells of the inner cortex and outer medulla. Stimulated by hypoxia (sensed by HIF: hypoxia-inducible factor)

43
Q

What are mechanisms of anemia in CKD

A
  • Decreased EPO production by peritubular interstitial cells (worsened by ACEIs)
  • Iron deficiency due to production of hepcidin (inhibits intestinal iron absorption + sequestrates it in macrophages) + chronic GI bleed + urinary iron losses
  • GI bleed due to uremic ulcers
  • Hemorrhage due to thrombocytopathy
  • RBC fragility and hemolysis due to uremic toxins
44
Q

What are complications of darbepoietin therapy

A
  • Anaphylaxis
  • Hypertension (increase in vascular resistance)
  • Pure red cell aplasia
  • Seizures
45
Q

Is unilateral or bilateral ureteral obstruction more likely to cause more severe kidney damage

A

Unilateral obstruction because it causes more afferent vasoconstriction (vs bilateral causes more efferent vasoconstriction)

46
Q

What are the 3 phases of vascular regulation with ureteral obstruction and their duration

A
  • Phase I (0-1.5h): afferent vasodilation
  • Phase II (1.5-5h): efferent vasoconstriction
  • Phase III (5-18h): afferent vasoconstriction
47
Q

What are 2 mechanisms of the loss for concentrating ability of the kidney after ureteral obstruction

A
  • Loss of hypertonicity of the medulla
  • Decreased response to ADH, downregulated transporters
48
Q

What proportion of cats with ureteral obstruction don’t have marked pelvic / ureteral dilation

A

About 25%

49
Q

True or false: Creatinine on presentation is a prognostic marker for cats with ureteral obstruction

A

False.
But marker of duration of hospitalization, and creat after discharge marker of mortality.

50
Q

What are the different types of casts that can be found in urine? Which can be normal?

A
  • Hyaline casts
  • Epithelial casts
  • Mixed cellular / granular casts
  • Coarse granular casts
  • Fine granular casts
  • Waxy casts

Hyaline and fine granular casts can be normal if < 2 / LPF in well concentrated urine

51
Q

What is the pathogenesis of leptospirosis in different organs

A

Leptospires invade endotheliums and break down endothelial barriers

  • Pulmonary hemorrhage: from disruption of endothelium
  • Liver dysfunction: from disruption of hepatocyte inter-cellular junctions (causing leakage of bile)
  • Direct cytotoxic effect on platelets causing decreased aggregation
  • Invasion of interstitium and tubular cells causing direct damage (tubular cell necrosis) and tubulointerstitial nephritis in kidneys
  • Vasculitis from endothelial damage
52
Q

What are common UA findings associated with leptospirosis

A
  • Isosthenuria (or less commonly hyposthenuria)
  • Glucosuria
  • Proteinuria (typically UPCR<5)
  • Bilirubinuria
  • Possible hematuria
53
Q

What are radiographic changes associated with pulmonary hemorrhage in leptospirosis

A

Bilateral interstitial pattern followed by reticulo-nodular pattern and generalized alveolar infiltrates

54
Q

What are supportive / confirmatory laboratory criteria of leptospirosis

A

Supportive:
- MAT titer > 1:800
- Detection of IgM lepto antibodies
- Positive urine PCR
- Visualization of leptospires in blood or urine on darkfield microscopy by reference laboratory

Confirmatory:
- 4-fold or higher increase in MAT titers between acute and convalescent (at same lab)
- Positive blood PCR
- Isolation of Leptospira from a clinical specimen by a reference lab

55
Q

What is required to diagnose a probable case of lepto vs a confirmed case

A

Probable case: meets clinical criteria and at least 1 supportive lab criteria

Confirmed case: meets clinical criteria and at least 1 confirmatory lab criteria

56
Q

What are the clinical criteria for leptospirosis

A
  1. Onset of systemic illness (fever, lethargy, PUPD, anorexia) within the past 2 weeks +/- signs suggestive of lepto:
    - GI
    - Pulmonary (cough, hemoptysis, tachypnea)
    - Ocular (uveitis, conjunctivitis, retinal hemorrhage)
    - AKI (oliguria)
    - Hepatobiliary (icterus)
    - Coagulation (hemorrhage)
  2. AND 2 or more clinicopathologic abnormalities:
    - Neutrophilic leukocytosis
    - Thrombocytopenia
    - Increased creat with isosthenuria
    - Cholestatic hepatopathy
    - Increased lipase
    - Increased CK
    - Glucosuria (with normal BG)
    - Active urine sediment
    - Rads consistent with pulmonary hemorrhage
    - Abd ultrasound consistent with lepto (pancreatitis, hyperechoic renal cortex, perirenal fluid)
    - Arrhythmias or increased cTnI
57
Q

What are the 4 vaccinal serovars for lepto in the US / Canada

A

Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, L. pomona
(Australis instead of Pomona in Europe)

58
Q

How should penicillin dosage be adjusted for dogs with AKI grade 4 and higher

A

Dosing interval should be doubled

59
Q

Is ursodeoxycholic acid (Ursodiol) recommended in leptospirosis?

A

No - not enough data and could worsen bile leakage

60
Q

When should RRT start being considered in dogs with lepto

A

When they are AKI grade 4 or higher (creat > 440)

61
Q

What is the prognosis for dogs with lepto treated with RRT

A

> 80% recovery

62
Q

What are negative prognostic factors for lepto in dogs

A

Hyperbilirubinemia (bilirubin >= 10 umol/L associated with death) and hypocoagulability

Pulmonary hemorrhage associated with 70% mortality

63
Q

For how long should zoonosis precautions be taken for dogs with leptospirosis

A

For 48h on antibiotics

(Protection include gloves, gowns, mask, eye protection)

64
Q

Should other dogs living in the household of a dog with lepto be treated with antimicrobials

A

Prophylactic treatment with doxycycline for 2 weeks is recommended (ideally with monitoring of MAT)

No evidence for cats at this point

65
Q

What is the most pathogenic species of Leptospira

A

Leptospira interrogans

66
Q

What are the 2 mechanisms which can lead to AKI in tumor lysis syndrome

A
  • Hyperphosphatemia -> precipitation of calcium phosphate in renal tubules
  • Hyperuricemia -> precipitation of urate crystals in kidneys
67
Q

What are the IRIS stages of AKI?

A

Grade I: Nonazotemic AKI (<140)
- Documented AKI and/or
- Progressive non azotemic increase in serum creat (>26.4 mol/L) with 48h and/or
- Measured oliguria (<1ml/kg/h) or anuria over 6h

Garde II: Mild AKI (141-220)
- Documented AKI and static or progressive azotemia
- Progresive azotemic increase in creat (> 26.4 umol/L) within 48h, serum responsiveness, and/or
- Measured oliguria (<1ml/kg/h) or anuria over 6h

Grade III: Moderate to severe AKI (221-439)
- Documented AKI ad increasing severities of azotemia and functional failure

Grade IV: 440-880

Grade V: > 880x

68
Q

How is fluid overload defined?

A

Fluid accumulation more than 10% of baseline body weight

69
Q

What is the median pelvic width in animals with normal renal function?

A

2mm

70
Q

Why is there a higher risk of hemorrhage secondary to renal tissue sampling in renal disease?

A

Uremic inhibition of platelet function

71
Q

Define oliguria

A

Urine production of < 1ml/kg/h after fluid volume restoration

72
Q

Why is the BUN to creatinine ratio often increased in pre-renal azotemia?

A

Due to the increased reabsorption of BUN in the nephron as a physiological response to re-establish euvolemic state (in presence of ADH)

73
Q

How does uraemia lead to oral ulceration?

A

Conversion of urea by bacterial urease into ammonia which is caustic to the oral mucosa.

74
Q

What are 5 mechanisms of oliguria?

A
  1. Decreased renal blood flow
  2. Tubular obstruction from casts or cellular debris
  3. Backflow of glomerular filtrate into renal interstitium
  4. Inrarenal renine-angiotensis system activation
  5. Altered permeability of glomerular filtration barrier
75
Q

What are the most important predictors of outcome for animals with AKI managed medically?

A
  • Etiology (reversibility?)
  • Severity (AKI grade)
  • Body systems involved
  • Comorbidities
  • Treatment quality
76
Q

In a 2022 JVIM paper on longterm outcome of dogs with AKI, what was the outcome?

A

Creat normalized in 75% of cases
- 55% at discharge and 20% during follow-up period (up to 3 months)

Estimated MST = 3.5 years

In dogs who’s creat did not normalize, median value was 167 mmol/L

** New data suggests good short and long term outcome in animals with AKI

77
Q

In which species can bilirubinuria be normal?

A

Dogs - more than 20% have 1+ bilirubinuria
* low renal threshold - expect bilirubinuria before bilirubinemia

78
Q

What serum calcium phosphorus product has been associated with shorter survival in dogs with CKD?

A

> 70 mg2/dL2

79
Q

What differentiates sepsis induced AKI from AKI due to ischemia or nephrotoxins?

A

Sepsis-induced AKI is characterized by marked reduction in kidney function with only mild histological changes in the kidney

VS diffuse glomerular and tubular damage with extensive necrosis in other forms of AKI

80
Q

Other than colloids, what fluids should be avoided in patients with AKI and why?

A

Chloride-rich fluids should be avoided. Has been associated with higher incidence of kidney injury possibly due to activation of macula densa and subsequent renal afferent arteriole vasoconstriction.

81
Q

True or false: The prophylactic use of furosemide to prevent AKI has been shown to be effective in critical illness.

A

False - ineffective and even harmful

82
Q

Why is Dopamine no longer recommended as a vasodilator in AKI?

A

At low doses in healthy individuals, dopamine causes renal vasodilation, increased GFR and diuresis.

–> These effects are not preserved in patients with AKI
–> In patients with AKI, dopamine increases renal vascular resistance and reduces RBF
–> Risk of tachyarrhythmias, myocardial hypoxia, reduced splanchnic blood flow and suppressed Tcell function

83
Q

Name 3 biomarkers that can be used to detect AKI before an increase in creatinine

A
  • Urinary neutrophil gelatinase associated lipocalin (NGAL)
  • Urinary cystatin C
  • Urinary N-acetyl-beta-D-glucosaminidase (NAG)
  • Urinary retinol-binding protein